RESEARCH FIELD
R&D Process
Scientific and replicable R&D process
In-house R&D Case study - 3D011
-
01Analyze demand
· Unmet medical needs exist for prostate cancer in China
-
02Identify a product or target
· Inhibit directly: RAF/MEK
· Inhibit indirectly: block tumor angiogenesis
-
03R&D
· Proprietary platform
· Unique pro-drug design targeted to specific organs and tumor types
-
043D011 (IND approved)
Compared to products of similar category:
other studies shows, VEGF could increase PD-1
expression on T-cells and mediate
“exhaustion” of CD8+ T-cells in tumors.
